Literature DB >> 29248335

Outpatient Management of Emergency Department Patients With Acute Pulmonary Embolism: Variation, Patient Characteristics, and Outcomes.

David R Vinson1, Dustin W Ballard2, Jie Huang3, Mary E Reed3, James S Lin4, Mamata V Kene5, Dana R Sax6, Adina S Rauchwerger3, David H Wang7, D Ian McLachlan8, Tamara S Pleshakov9, Matthew A Silver10, Victoria A Clague11, Andrew S Klonecke12, Dustin G Mark13.   

Abstract

STUDY
OBJECTIVE: Outpatient management of emergency department (ED) patients with acute pulmonary embolism is uncommon. We seek to evaluate the facility-level variation of outpatient pulmonary embolism management and to describe patient characteristics and outcomes associated with home discharge.
METHODS: The Management of Acute Pulmonary Embolism (MAPLE) study is a retrospective cohort study of patients with acute pulmonary embolism undertaken in 21 community EDs from January 2013 to April 2015. We gathered demographic and clinical variables from comprehensive electronic health records and structured manual chart review. We used multivariable logistic regression to assess the association between patient characteristics and home discharge. We report ED length of stay, consultations, 5-day pulmonary embolism-related return visits and 30-day major hemorrhage, recurrent venous thromboembolism, and all-cause mortality.
RESULTS: Of 2,387 patients, 179 were discharged home (7.5%). Home discharge varied significantly between EDs, from 0% to 14.3% (median 7.0%; interquartile range 4.2% to 10.9%). Median length of stay for home discharge patients (excluding those who arrived with a new pulmonary embolism diagnosis) was 6.0 hours (interquartile range 4.6 to 7.2 hours) and 81% received consultations. On adjusted analysis, ambulance arrival, abnormal vital signs, syncope or presyncope, deep venous thrombosis, elevated cardiac biomarker levels, and more proximal emboli were inversely associated with home discharge. Thirteen patients (7.2%) who were discharged home had a 5-day pulmonary embolism-related return visit. Thirty-day major hemorrhage and recurrent venous thromboembolism were uncommon and similar between patients hospitalized and those discharged home. All-cause 30-day mortality was lower in the home discharge group (1.1% versus 4.4%).
CONCLUSION: Home discharge of ED patients with acute pulmonary embolism was uncommon and varied significantly between facilities. Patients selected for outpatient management had a low incidence of adverse outcomes.
Copyright © 2017 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29248335     DOI: 10.1016/j.annemergmed.2017.10.022

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  12 in total

1.  Text message alerts to emergency physicians identifying potential study candidates increase clinical trial enrollment.

Authors:  Laura E Simon; Adina S Rauchwerger; Uli K Chettipally; Leon Babakhanian; David R Vinson; E Margaret Warton; Mary E Reed; Anupam B Kharbanda; Elyse O Kharbanda; Dustin W Ballard
Journal:  J Am Med Inform Assoc       Date:  2019-11-01       Impact factor: 4.497

2.  Management and Outcomes of Adults Diagnosed with Acute Pulmonary Embolism in Primary Care: Community-Based Retrospective Cohort Study.

Authors:  David R Vinson; Erik R Hofmann; Elizabeth J Johnson; Suresh Rangarajan; Jie Huang; Dayna J Isaacs; Judy Shan; Karen L Wallace; Adina S Rauchwerger; Mary E Reed; Dustin G Mark
Journal:  J Gen Intern Med       Date:  2022-01-12       Impact factor: 6.473

3.  Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.

Authors:  Rasha Khatib; Stephanie Ross; Sean Alexander Kennedy; Ivan D Florez; Thomas L Ortel; Robby Nieuwlaat; Ignacio Neumann; Daniel M Witt; Sam Schulman; Veena Manja; Rebecca Beyth; Nathan P Clark; Wojtek Wiercioch; Holger J Schünemann; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-02-11

4.  Diagnostic Performance of Emergency Physician Gestalt for Predicting Acute Appendicitis in Patients Age 5 to 20 Years.

Authors:  Laura E Simon; Mamata V Kene; E Margaret Warton; Adina S Rauchwerger; David R Vinson; Mary E Reed; Uli K Chettipally; Dustin G Mark; Dana R Sax; D Ian McLachlan; Dale M Cotton; James S Lin; Gabriela Vazquez-Benitez; Anupam B Kharbanda; Elyse O Kharbanda; Dustin W Ballard
Journal:  Acad Emerg Med       Date:  2020-04-02       Impact factor: 3.451

5.  Emergency Department Patient Satisfaction with Treatment of Low-risk Pulmonary Embolism.

Authors:  Laura E Simon; Hilary R Iskin; Ridhima Vemula; Jie Huang; Adina S Rauchwerger; Mary E Reed; Dustin W Ballard; David R Vinson
Journal:  West J Emerg Med       Date:  2018-10-18

Review 6.  Reducing the hospital burden associated with the treatment of pulmonary embolism.

Authors:  W Frank Peacock; Adam J Singer
Journal:  J Thromb Haemost       Date:  2019-04-01       Impact factor: 5.824

7.  Comprehensive Outpatient Management of Low-Risk Pulmonary Embolism: Can Primary Care Do This? A Narrative Review.

Authors:  David R Vinson; Drahomir Aujesky; Geert-Jan Geersing; Pierre-Marie Roy
Journal:  Perm J       Date:  2020-03-13

8.  Outpatient Management of Patients Following Diagnosis of Acute Pulmonary Embolism.

Authors:  Lauren M Westafer; Meng-Shiou Shieh; Penelope S Pekow; Mihaela S Stefan; Peter K Lindenauer
Journal:  Acad Emerg Med       Date:  2020-12-19       Impact factor: 3.451

9.  Outpatient management of patients presenting with venous thromboembolism: Retrospective cohort study at 11 community hospitals.

Authors:  Rasha Khatib; Kara Nitti; Marc McDowell; Rick Szymialis; Chris Blair; Nicole Glowacki; William Rhoades
Journal:  J Thromb Thrombolysis       Date:  2020-11-07       Impact factor: 2.300

10.  Acute Pulmonary Embolism in Emergency Department Patients Despite Therapeutic Anticoagulation.

Authors:  Michelle Y Liu; Dustin W Ballard; Jie Huang; Adina S Rauchwerger; Mary E Reed; Sean C Bouvet; David R Vinson
Journal:  West J Emerg Med       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.